Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) membrane (M) protein inhibits type I and III interferon production by targeting RIG-I/MDA-5 signaling.
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) membrane (M) protein inhibits type I and III interferon production by targeting RIG-I/MDA-5 signaling.
复制标题
严重急性呼吸综合征冠状病毒 2 (SARS-CoV-2) 膜 (M) 蛋白通过靶向 RIG-I/MDA-5 信号传导抑制 I 型和 III 型干扰素产生
DOI:
10.1038/s41392-020-00438-7
复制
发表时间:
2020-12-28
影响因子:
39.3
通讯作者:
Wang PH
中科院分区:
文献类型:
--
作者:
Zheng Y;Zhuang MW;Han L;Zhang J;Nan ML;Zhan P;Kang D;Liu X;Gao C;Wang PH
Coronavirus disease 2019 (COVID-19), caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), has quickly spread worldwide and has affected more than 10 million individuals. A typical feature of COVID-19 is the suppression of type I and III interferon (IFN)-mediated antiviral immunity. However, the molecular mechanism by which SARS-CoV-2 evades antiviral immunity remains elusive. Here, we reported that the SARS-CoV-2 membrane (M) protein inhibits the production of type I and III IFNs induced by the cytosolic dsRNA-sensing pathway mediated by RIG-I/MDA-5–MAVS signaling. In addition, the SARS-CoV-2 M protein suppresses type I and III IFN induction stimulated by SeV infection or poly (I:C) transfection. Mechanistically, the SARS-CoV-2 M protein interacts with RIG-I, MAVS, and TBK1, thus preventing the formation of the multiprotein complex containing RIG-I, MAVS, TRAF3, and TBK1 and subsequently impeding the phosphorylation, nuclear translocation, and activation of IRF3. Consequently, ectopic expression of the SARS-CoV-2 M protein facilitates the replication of vesicular stomatitis virus. Taken together, these results indicate that the SARS-CoV-2 M protein antagonizes type I and III IFN production by targeting RIG-I/MDA-5 signaling, which subsequently attenuates antiviral immunity and enhances viral replication. This study provides insight into the interpretation of SARS-CoV-2-induced antiviral immune suppression and illuminates the pathogenic mechanism of COVID-19.
登录
查看更多内容
影响因子:
32.4
作者:
Ni, Ling;Ye, Fang;Dong, Chen
通讯作者:
Dong, Chen
影响因子:
56.9
作者:
Broggi, Achille;Ghosh, Sreya;Zanoni, Ivan
通讯作者:
Zanoni, Ivan
DOI:
10.1074/jbc.m109.008227
发表时间:
2009-06-12
期刊:
The Journal of biological chemistry
影响因子:
--
作者:
Siu KL;Kok KH;Ng MJ;Poon VKM;Yuen KY;Zheng BJ;Jin DY
通讯作者:
Jin DY
影响因子:
13.2
作者:
Lui PY;Wong LY;Fung CL;Siu KL;Yeung ML;Yuen KS;Chan CP;Woo PC;Yuen KY;Jin DY
通讯作者:
Jin DY
影响因子:
16.6
作者:
Lei, Xiaobo;Dong, Xiaojing;Wang, Jianwei
通讯作者:
Wang, Jianwei